Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
UBS
Express Scripts
Colorcon
Chubb
Baxter
US Department of Justice
McKesson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200880

« Back to Dashboard

NDA 200880 describes ACETAZOLAMIDE SODIUM, which is a drug marketed by Hospira, Mylan Asi, Par Sterile Products, West-ward Pharms Int, X Gen Pharms, and Emcure Pharms Ltd, and is included in six NDAs. It is available from four suppliers. Additional details are available on the ACETAZOLAMIDE SODIUM profile page.

The generic ingredient in ACETAZOLAMIDE SODIUM is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
Summary for 200880
Tradename:ACETAZOLAMIDE SODIUM
Applicant:Mylan Asi
Ingredient:acetazolamide sodium
Patents:0
Therapeutic Class:Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 200880
Ingredient-typeSulfonamides
Mechanism of ActionCarbonic Anhydrase Inhibitors
Suppliers and Packaging for NDA: 200880
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 200880 ANDA Sagent Pharmaceuticals 25021-817 N 25021-817-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:May 9, 2012TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Healthtrust
Baxter
Cerilliant
Boehringer Ingelheim
Chubb
Dow
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.